glp-1 receptor agonist after roux-en-y gastric bypass Interest in Treatment with Agonists for the Management of Insufficient Weight Loss or Weight Regain Bariatric Surgery | Obesity Surgery Greater early postprandial GLP-1 increase
Description
Initially developed to improve glycemic control, these agents are now recognized as important components of cardiovascular risk reduction strategies
The primary outcome was change in HbA1c from baseline
See if you qualify for compensation and how to file.
Society guidelines have left clinicians with some questionable recommendations
